| Structure |
Chemical Name |
CAS |
MF |
 |
Hyoscine Butylbromide EP Impurity G |
|
|
 |
Cefminox Sodium Impurity 3 |
1420072-83-8 |
C16H21N7O6S4 |
 |
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
|
|
Edaravone Impurity 26 |
152494-76-3 |
|
 |
Levofloxacin Impurity 24 |
|
C18H20FN3O4 |
 |
カフェイジン |
20041-90-1 |
C7H12N4O |
 |
Norepinephrine Impurity 23 |
1528622-09-4 |
C9H13NO3 |
 |
Brexpiprazole Impurity 77 |
1783311-11-4 |
C12H14N2S |
|
|
メトレレプチン（遺伝子組換え） |
186018-45-1 |
|
 |
(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol |
114218-35-8 |
C15H26ClNO3 |
 |
1-Pentanone, 1-(2-hydroxy-5-methylphenyl)- |
150033-77-5 |
C12H16O2 |
 |
3,5-ジヨード-4-(4-ヒドロキシ-3,5-ジヨードフェノキシ)安息香酸 |
2055-97-2 |
C13H6I4O4 |
 |
PLSQ-001 TM4-QJ |
1227162-74-4 |
C18H24N2O2 |
![SOTALOL RELATED COMPOUND C (N-[4-[2-[(1-メチルエチル)アミノ]エチル]フェニル]メタンスルホンアミド MONOHYDROCHLORIDE)](/CAS/GIF/16974-42-8.gif) |
SOTALOL RELATED COMPOUND C (N-[4-[2-[(1-メチルエチル)アミノ]エチル]フェニル]メタンスルホンアミド MONOHYDROCHLORIDE) |
16974-42-8 |
C12H20N2O2S |
 |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid |
2101641-92-1 |
C7H13BrO2 |
![3β-[(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)オキシ]-12β,14-ジヒドロキシ-5β,14β-カルダ-20(22)-エノリド](/CAS/GIF/5352-63-6.gif) |
3β-[(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)オキシ]-12β,14-ジヒドロキシ-5β,14β-カルダ-20(22)-エノリド |
5352-63-6 |
C29H44O8 |
![2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3)](/CAS/20211123/GIF/2095467-43-7.gif) |
2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3) |
2095467-43-7 |
C15H20ClN3 |
 |
2-(ジメチルアミノ)-N-(2,6-ジメチルフェニル)アセトアミド |
21236-54-4 |
C12H18N2O |
|
|
Posaconazole Impurity 27 |
|
|
 |
Posaconazole Impurity 44 |
357189-97-0 |
C21H20F2N4O3 |
|
|
Pramipexole Impurity 10 |
|
|
 |
(βR)-N-(ベンジルオキシカルボニル)-β-ヒドロキシ-3,4-ビス-(ベンジルオキシ)-L-フェニルアラニン |
55382-14-4 |
C31H29NO7 |
|
|
(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol |
|
|
|
|
Dapagliflozin Impurity (MW:423Da) |
|
|
|
|
Ramipril - Isomer Impurity 1 |
|
|
|
|
Aripiprazole peroxide degradation Impurity (MW:480Da) |
|
|
|
|
Fosinopril Sodium Impurity A (Fosinoprilat) |
|
|
|
|
Dapoxetine Impurity 40 |
|
|
|
|
Doxofylline Impurity 15 |
|
|
|
|
Iohexol Impurity 10 |
|
|
|
|
Benzylpenicillin EP(CP) Impurity F |
|
|
 |
Butyphthalide impurity 27 |
33704-16-4 |
C12H12O5 |
|
|
Butyphthalide impurity 35 |
|
|
|
|
Canagliflozin Impurity 31 |
|
|
 |
Celecoxib Impurity 21 |
2055787-31-8 |
C17H12F3N3O3S |
|
|
Emtricitabine Impurity CFTU2 |
|
|
|
|
Febuxostat Impurity 88 |
|
|
|
|
Gefitinib Impurity S |
|
|
 |
Ibrutinib Impurity 15 |
1288338-97-5 |
C47H46N12O3 |
|
|
LCZ696(valsartan + sacubitril) impurity 34 |
|
|
|
|
Lenvatinib Impurity 27 |
|
|
|
|
Montelukast sodium impurity H |
|
|
|
|
Regorafenib Impurity 25 |
|
|
|
|
Regorafenib Impurity 33 |
|
|
|
|
Sitafloxacin Impurity ZZ-A-02 |
|
|
 |
Solifenacin impurity 19 |
1422505-78-9 |
C17H17NO |
![2-{[2-(4-ヒドロキシベンゼンスルホンアミド)フェニル]ホルムアミド}酢酸](/CAS/20180808/GIF/155023-59-9.gif) |
2-{[2-(4-ヒドロキシベンゼンスルホンアミド)フェニル]ホルムアミド}酢酸 |
155023-59-9 |
C15H14N2O6S |
![2-クロロ-10-[3-(メチルアミノ)プロピル]-10H-フェノチアジン](/CAS/GIF/1225-64-5.gif) |
2-クロロ-10-[3-(メチルアミノ)プロピル]-10H-フェノチアジン |
1225-64-5 |
C16H17ClN2S |
 |
1,3,5,7-Tetrmethyl-adamantane |
1687-36-1 |
C14H24 |
 |
4'-ヒドロキシアセトフェノンオキシム |
34523-34-7 |
C8H9NO2 |
 |
4-(4-フルオロフェニル)-2-シクロプロピルキノリン-3-カルボン酸メチルエステル |
121659-86-7 |
C20H16FNO2 |
![α,α-Bis[2-(dimethylamino)ethyl]-](/CAS/GIF/1246816-57-8.gif) |
α,α-Bis[2-(dimethylamino)ethyl]- |
1246816-57-8 |
C16H24ClN3 |
 |
2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil |
1185256-03-4 |
C33H34N6O6 |
 |
N-Desethyl-N-propyl Oxybutynin |
1215677-72-7 |
C23H33NO3 |
|
|
Tofacitinib Impurity 93 |
|
|
|
|
Topiroxostat Impurity 30 |
|
|
|
|
Sitafloxacin Impurity 8 |
|
|
 |
Budesonide Impurity 7 |
3949-79-9 |
C23H28O7 |
 |
Diazepam Impurity 1 |
36020-94-7 |
C16H15ClN2O2 |
 |
Rosuvastatin Related Compound 8 |
521974-01-6 |
C13H23ClO4 |
|
|
Aztreonam Impurity 8 |
|
|
 |
(1s,4s)-4-((2-amino-4-bromobenzyl)amino)cyclohexan-1-ol hydrochloride |
|
C13H20BrClN2O |
 |
Pitavastatin Impurity 18 Sodium Salt |
2276678-27-2 |
C25H25FNNaO5 |
 |
Moxifloxacin Impurity 67 |
1430075-14-1 |
C10H16ClNO3 |
|
|
Landiolol impurity |
|
|
|
|
Irinotecan Impurity K |
|
|
|
|
Palbociclib Impurity 28 |
|
|
|
|
Vildagliptin Impurity 37 |
|
|
 |
Tazobactam Impurity B |
115546-66-2 |
C10H12N4O5S |
 |
Brexpiprazole Impurity 20 |
105685-34-5 |
C12H14N2O |
|
|
Pralatrexate Impurity 13 |
|
|
|
|
Pralatrexate Impurity 18 |
|
|
|
|
Pitavastatin Impurity 50 |
|
|
|
|
Pitavastatin Impurity 58 |
|
|
|
|
Lenvatinib Impurity 41 |
|
|
|
|
Tazobactam Impurity 12 |
|
|
|
|
Tofacitinib Impurity 103 |
|
|
|
|
Posaconazole impurity 69 |
|
|
|
|
Crisaborole Impurity 3 |
|
|
|
|
Canagliflozin Impurity 59 |
|
|
|
|
Canagliflozin Impurity 64 |
|
|
|
|
Hydroxychloroquine Impurity I |
|
|
|
|
Sitafloxacin Impurity 22 |
|
|
|
|
Levetiracetam Impurity 24 |
|
|
 |
Selexipag Impurity 5 |
2928611-79-2 |
C22H23N3O3 |
|
|
Levosimendan Impurity 11 |
|
|
|
|
Cabozantinib impurity O |
|
|
![(41S,12S,13aS)-12-(ethoxycarbonyl)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydroindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine 4(1H)-oxide](/CAS/20210111/GIF/52341-36-3.gif) |
(41S,12S,13aS)-12-(ethoxycarbonyl)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydroindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine 4(1H)-oxide |
52341-36-3 |
C22H28N2O4 |
|
|
Rotigotine Impurity 5 |
|
|
|
|
Rotigotine Impurity 10 |
|
|
 |
(2S)-シクロペンチル(ヒドロキシ)(フェニル)酢酸 |
64471-43-8 |
C13H16O3 |
|
|
Olprinone Impurity 6 |
|
|
 |
Trenbolone Acetate Process Impurity 4 |
5218-51-9 |
C18H24O2 |
|
|
Cilastatin Impurity 6 |
|
|
 |
Sitagliptin Impurity 77 |
382638-00-8 |
C11H21NO7S |
|
|
Trimetazidine Impurity 6 |
|
|
 |
Oseltamivir Impurity 50 |
651324-06-0 |
C24H42N2O3 |
 |
Tamsulosin impurity 6 |
|
C20H28N2O5S |
|
|
Flucloxacillin Impurity 6 |
|
|
 |
Ipratropium bromide Impurity 3 |
|
C20H29Br2NO3 |